risks of taking glp 1 Key Takeaways Patients GLP-1 receptor agonists for weight loss had a 41% lower risk obesity-associated cancers compared with patients prescribed diet or exercise. Patients taking tirzepatide had substantially greater cancer Glucagon-like Receptor-1 agonists for obesity:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16


























